Esperion Therapeutics (NasdaqGM:ESPR) Q4 2025 Earnings call March 10, 2026 08:00 AM ET Company ParticipantsBen Halladay - CFOJohn Harlow - Chief Commercial OfficerSheldon Koenig - President and CEOTiffany Aldrich - Head of Corporate CommunicationsConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystGeorgia Bank - Research AnalystJason Zemansky - VP and SMid-Cap Biotech AnalystJoe Pantginis - Managing Director and Senior Healthcare AnalystKristen Kluska - Managing Directo ...